We were happy to host Tamás Petrovics, Co-Founder & CEO of XUND, and Balázs Haszonics, Managing Partner at Lead Ventures.

Fresh off the announcement of XUND’s €6M Pre-Series A round, this fireside chat highlighted how the Vienna-founded, Budapest-based healthtech scale-up is building Software as a Medical Device (SaMD) to bring clarity to the most important decisions in healthcare.

​XUND is shaping the future of AI-powered diagnostics and patient journeys, working with leading insurers and hospitals while expanding rapidly in the DACH region and the UK. Their latest raise, backed by Lead Ventures and J&T Ventures, is aimed at fueling expansion and scaling their MDR-certified solutions even further—firmly positioning the company as a European AI healthtech leader.

​One of their investors, Lead Ventures, backs B2B software startups from CEE and the Baltics that are ready to scale. Beyond capital, they offer strategic guidance, network access, and support to help companies expand internationally.